Rainbow Childrens Medicare Ltd Q1 FY27 Earnings Analysis
Published 13 Jun 2026 | Healthcare Services | Market Cap: ₹12.7K Cr
Price
₹1,365
Market Cap
₹12.7K Cr
P/E Ratio
49.4
Revenue Rank
Margin Rank
Earnings Summary
- The company expects mature hospitals to operate at around 60% occupancy in the coming year, up from current 54%-56%, supporting growth targets. - The company aims for an aspirational yet achievable growth rate of 20% in the current year (FY27) while maintaining margins.
📊 Revenue & Sales Performance
Rank 3- The company expects mature hospitals to operate at around 60% occupancy in the coming year, up from current 54%-56%, supporting growth targets. - Blended occupancy across the network is expected in the range of 56%-57%. - Revenue growth is anticipated around 20% for the upcoming financial year, driven by improved case mix, specialty services, and fertility business expansion. - Fertility segment is projected to grow at approximately 25% year-on-year for the next three years. - Expansion and ramp-up expected in key markets like Hyderabad, Bangalore, Chennai, and Andhra Pradesh. - Ongoing investments in digital marketing and technology aim to improve patient engagement and lead conversion, supporting volume growth. - The company remains open to acquisitions pan-India to add scalable hospitals in attractive micro-markets, aiding geographic and volume expansion. - Enhanced specialty services, including super-specialty areas like liver transplantation, planned to drive higher top-line growth.
📈 Profitability & Margins
Rank 3- The company aims for an aspirational yet achievable growth rate of 20% in the current year (FY27) while maintaining margins. (Page 5) - EBITDA growth was 26% in Q4 FY26 and 11% for full FY26, suggesting a strong operating leverage to build on. (Page 5) - Profit After Tax (PAT) grew 15.3% in FY26; management expects continued growth supported by operational initiatives. (Page 6) - Growth drivers include improving occupancy (targeting 56%-58% blended occupancy), enhancing service mix, and ramping up specialty services such as liver transplantation. (Page 16, 19) - ARPP (Average Revenue per Patient) expected to grow by around 5%-6% annually, providing steady revenue growth potential. (Page 18) - Expansion through organic capacity additions (approx. 900 beds in pipeline) and acquisitions in scalable and strategic locations may bolster earnings. (Page 6) - Fertility business expected to grow at approximately 25% year-on-year for the next three years, adding to revenue diversification. (Page 15)
🏗️ Capital Expenditure Plans
Yes- Maintenance capex is approximately INR 45 crores per year across ~25 units. - Growth capex includes: - Around INR 400–500 crores expected for Gurugram projects over the next two years. - For other projects (Coimbatore, Pune, Indore, etc.), capex intensity is around INR 65–70 lakhs per bed. - Indore hospital planned for ~100 beds, capex included in pipeline. - Total development pipeline includes about 900 beds; excluding Gurugram, ~450 beds with capex aligned to bed numbers. - Gurugram projects: - Sector 56 (125 beds) targeted to commence operations in H2 FY28. - Sector 44 (325 beds) super specialty hub expected by Q1 FY29. - Pune regional greenfield hub hospital (150 beds) is in permission stage with excavation work ongoing. - Bangalore city will get a new 80-bed spoke hospital in a growing micro-market (Seegehalli). - Indore 100-bed hospital is in permission phase; partner handles base building; Rainbow invests in interiors and equipment. - All expansions funded via internal accruals; no incremental borrowing planned.
💰 Fundraising & Capital Structure
No- Rainbow Children's Medicare Limited currently has no debt on its books and maintains a strong cash position (~INR 600 crores in cash and cash equivalents as of May 2026). - All expansion and capital expenditure programs to date have been funded through internal accruals. - The company’s development pipeline, including approximately 900 beds under development, is expected to be funded through internal cash generation. - At this stage, there is no anticipated need for incremental borrowing to support growth plans. - The company is committed to a prudent and conservative capital structure while funding expansions. - No mention of equity fundraising or plans for future equity issuance was indicated in the provided transcript.
📋 Order Book & Pipeline
No information- Rainbow Children’s Medicare Limited has a development pipeline of approximately 900 beds in various stages of development and operationalization. - Investment required for new facilities in Coimbatore, Pune, Indore, and others is roughly INR 300–350 crores. - Additionally, approx INR 400–500 crores is expected to be invested in Gurugram projects over the next two years. - All expansion and capital expenditure are planned to be funded through internal accruals; no incremental borrowing is currently anticipated. - The company maintains a strong cash position (~INR 600 crores) and a debt-free balance sheet to support ongoing and planned growth initiatives.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Rainbow Childrens Medicare Ltd Q1 FY27 results?
- The company expects mature hospitals to operate at around 60% occupancy in the coming year, up from current 54%-56%, supporting growth targets. - The company aims for an aspirational yet achievable growth rate of 20% in the current year (FY27) while maintaining margins.
What is Rainbow Childrens Medicare Ltd share price analysis?
Rainbow Childrens Medicare Ltd currently shows a below-average growth signal. The stock trades at a P/E of 49.4 with a market cap of ₹12,718. Investors should review the full earnings analysis for detailed insights.
Is Rainbow Childrens Medicare Ltd planning capital expenditure?
- Maintenance capex is approximately INR 45 crores per year across ~25 units.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
